EUVIMEDEUVIMED entdecken
Crossref

PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway

Xiaoqing Li, Zhongxiang Jiang, Junfeng Li, Kun Yang, Jin He, Qianxi Deng, Shuman Xu, Zhihang Jiang, Fuqiang Liu, Zheng Jiang

Apoptosis · 2025-02 · 30 (1-2) · 16-34

DOI: 10.1007/s10495-024-02015-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Apoptosis, online erschienen am 06.09.2024. Verfasst von Xiaoqing Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Colorectal Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: The First Affiliated Hospital of Chongqing Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionColorectal NeoplasmsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesNeovascularization, PathologicFibroblast Growth Factor 1ProteoglycansExtracellular Matrix ProteinsHumansAnimalsMiceSignal TransductionCell ProliferationCell Line, TumorMice, NudeCell MovementMaleBevacizumabXenograft Model Antitumor AssaysDisease ProgressionMice, Inbred BALB CFemaleApoptosisGene Expression Regulation, NeoplasticAngiogenesis

Stichwörter der Autor:innen

AngiogenesisColorectal cancerEpithelial-mesenchymal transitionFGF1PRELP

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesFibroblast Growth Factor 1BevacizumabProteoglycansExtracellular Matrix Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. jiangz1753@hospital.cqmu.edu.cn.

Förderung

  • The First Affiliated Hospital of Chongqing Medical University

Zitieren

APA

Li, X., Jiang, Z., Li, J., Yang, K., He, J., Deng, Q., Xu, S., Jiang, Z., Liu, F., & Jiang, Z. (2025). PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway. Apoptosis, 30(1-2), 16-34. https://doi.org/10.1007/s10495-024-02015-7

Vancouver

Li X, Jiang Z, Li J, Yang K, He J, Deng Q, et al. PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway. Apoptosis. 2025;30(1-2):16-34. doi:10.1007/s10495-024-02015-7

BibTeX
@article{Li2025,
  author = {Li, Xiaoqing and Jiang, Zhongxiang and Li, Junfeng and Yang, Kun and He, Jin and Deng, Qianxi and Xu, Shuman and Jiang, Zhihang and Liu, Fuqiang and Jiang, Zheng},
  title = {PRELP inhibits colorectal cancer progression by suppressing epithelial-mesenchymal transition and angiogenesis via the inactivation of the FGF1/PI3K/AKT pathway},
  journal = {Apoptosis},
  year = {2025},
  volume = {30},
  number = {1-2},
  pages = {16--34},
  doi = {10.1007/s10495-024-02015-7}
}
Kostenlos starten →